27 Dec, 09:39 - Indian

SENSEX 78733.87 (0.33)

Nifty 50 23840.19921875 (0.38)

Nifty Bank 51384.8984375 (0.42)

Nifty IT 43560.3515625 (-0.24)

Nifty Midcap 100 57200.1015625 (0.13)

Nifty Next 50 69289.1015625 (0.18)

Nifty Pharma 22856.30078125 (0.63)

Nifty Smallcap 100 18771 (0.23)

27 Dec, 09:39 - Global

NIKKEI 225 40213.56 (1.63)

HANG SENG 20121.8 (0.12)

S&P 6097 (-0.17)

Cancel

BSE Code : 533573 | NSE Symbol : APLLTD | ISIN : INE901L01018 | Industry : Pharmaceuticals |

(20-Dec-24 18:30) Alembic Pharmaceuticals receives USFDA approval for Divalproex Sodium
(20-Dec-24 14:20) Alembic Pharma gets USFDA nod for seizure treatment drug
(11-Dec-24 12:39) Alembic Pharma Panelav unit clears Brazil GMP audit
(04-Dec-24 16:41) Alembic Pharma receives USFDA's tentative approval for Olopatadine Hydrochloride Ophthalmic Solution
(04-Dec-24 14:54) Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride eye drops
(25-Nov-24 11:19) Alembic Pharma Gujarat facility gets 5 observations from USFDA
(12-Nov-24 14:59) Alembic Pharmaceuticals receives USFDA approval for Ivabradine Tablets
(11-Nov-24 09:47) Alembic Pharma gets US FDA nod for Diltiazem Hydrochloride ER capsules
(11-Nov-24 09:03) Alembic Pharmaceuticals receives USFDA approval for Diltiazem Hydrochloride ER capsules
(07-Nov-24 14:16) Alembic Pharmaceuticals consolidated net profit rises 12.34% in the September 2024 quarter

1 2 3 4 5 6 7 8 9 10

Alembic Pharmaceuticals Ltd